The United Kingdom government has announced its plan to accelerate research into mRNA cancer vaccines in an agreement signed with pharmaceutical company BioNTech.
After the rollout of COVID-19 vaccines, BioNTech will trial a cancer treatment in Britain using the same mRNA technology.